Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001539497-25-001480·Bausch Health Companies Inc.
Schedule 13D ownership disclosure
Bausch Health Cos., Inc.
Common Stock, no par value · CUSIP: 071734107
Event date: 2025-05-20
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Icahn Partners Master Fund LPReported CIK 0001322827
Shares: 14,423,595.00 · Class: 3.9%
- Icahn Offshore LPReported CIK 0001322825
Shares: 14,423,595.00 · Class: 3.9%
- Icahn Partners LPReported CIK 0001313666
Shares: 20,297,523.00 · Class: 5.5%
- Icahn Onshore LPReported CIK 0001322826
Shares: 20,297,523.00 · Class: 5.5%
- Icahn Capital LPReported CIK 0001412093
Shares: 34,721,118.00 · Class: 9.4%
- IPH GP LLCReported CIK 0001412091
Shares: 34,721,118.00 · Class: 9.4%
- Icahn Enterprises Holdings L.P.Reported CIK 0001034563
Shares: 34,721,118.00 · Class: 9.4%
- Icahn Enterprises G.P. Inc.Reported CIK 0001257324
Shares: 34,721,118.00 · Class: 9.4%
- Beckton Corp.Reported CIK 0001080113
Shares: 34,721,118.00 · Class: 9.4%
- Carl C. IcahnReported CIK 0000921669
Shares: 34,721,118.00 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001539497-25-001480
- Form type
- SCHEDULE 13D/A
- Filer
- Bausch Health Companies Inc.
- CIK
- CIK 885590
- Filed
- May 21, 2025
- Reporting period
- May 20, 2025
- Description
- Schedule 13D beneficial ownership